Clinical Trial Update: Topical Interferon Gamma-1b for Central Serous Chorioretinopathy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating topical interferon gamma-1b for central serous chorioretinopathy has been completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Drugs mentioned

• Interferon-gamma 1b (interferon gamma-1b)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Retinal Disease, Macular Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-11-19